COMMUNIQUÉS West-GlobeNewswire

athenahealth Reports Third Quarter Fiscal Year 2018 Results
09/11/2018
Company Reaffirms Fiscal Year 2018 Financial Outlook WATERTOWN, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN) (“athenahealth” or “we”), a leading provider of network-enabled services for [...]
OPKO Health Reports Third Quarter 2018 Financial Results
09/11/2018
Conference Call begins today at 4:15 p.m. Eastern Time MIAMI , Nov. 09, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) reports financial results and business highlights for the three months ended September 30, [...]
LeMaitre Vascular to Present at Upcoming Investor Conferences
09/11/2018
BURLINGTON, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting at four conferences in November. David Roberts, President, is scheduled to present at [...]
TESARO Announces Immuno-Oncology Data Presentations at SITC 2018 Annual Meeting
09/11/2018
Initial data from AMBER trial of TSR-022 (anti-TIM-3) in combination with TSR-042 (anti-PD-1) demonstrated clinical activity in patients who have progressed following anti-PD-1 treatment TSR-042 monotherapy demonstrated [...]
Unum Therapeutics to Present Preclinical Data on Applications of ACTR Proprietary Technology Platform in Solid Tumors at the San Antonio Breast Cancer Symposium
09/11/2018
Initiating Phase 1 ATTCK-34-01 Trial in HER2+ Advanced Cancers by Year-End CAMBRIDGE, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on [...]
Adamas to Present at Three November Investor Conferences
09/11/2018
EMERYVILLE, Calif., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system disorders, [...]
Unilever and Bio-on work together to reduce environmental impact in the Personal Care sector
09/11/2018
Rome (Italy), 9 November 2018 - Unilever and Bio-on announce the start of a strategic partnership to develop, produce and sell personal hygiene and care products that guarantee a smaller or no environmental impact. [...]
Chembio Ebola Virus Diagnostic Test Receives U.S. FDA Emergency Use Authorization
09/11/2018
MEDFORD, N.Y., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care ("POC") diagnostics company focused on infectious diseases, today announced the receipt of U.S. Food and [...]
Gradalis® Presents Initial Data from Phase II U.S. Trial for Ewing’s sarcoma at the Annual Meeting of the Children’s Oncology Group
09/11/2018
DALLAS, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Gradalis, Inc., a clinical-stage immunotherapy company developing investigational treatments for individuals suffering from multiple cancer indications, presented initial data [...]
Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2019
09/11/2018
DUBLIN - November 9, 2018 - Medtronic plc (NYSE:MDT) announced today that it will report financial results for the second quarter of fiscal year 2019 on Tuesday, November 20, 2018. A news release will be issued at [...]
Next Green Wave’s Unique Business Model Yields Greater Potential -- CFN Media
09/11/2018
SEATTLE, Nov. 09, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
iCAD Announces Retirement of CEO, Ken Ferry
09/11/2018
Michael Klein, Chairman of the Board, to serve as Executive Chairman and Interim CEO NASHUA, N.H., Nov. 09, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative [...]
Novelion Therapeutics Reports Third Quarter 2018 Financial Results
09/11/2018
VANCOUVER, British Columbia, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN), a biopharmaceutical company dedicated to developing and commercializing therapies for individuals living with [...]
NICE publishes advice on gammaCore for the treatment of cluster headache in the UK
09/11/2018
Report contributors agreed gammaCore was highly innovative, may be more effective than standard of care alone, and has the potential to save money through the NHS by reducing the cost of treating cluster headache [...]
Ultragenyx to Present at Upcoming Investor Conferences
09/11/2018
NOVATO, Calif., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Hemostemix Announces Development of an ACP-01 Allogeneic Process and Initiation of R&D for Autologous NCP-01 Neural Cellular Precursors
09/11/2018
CALGARY, Alberta, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to provide the following update on its research and development [...]
Caladrius Biosciences to Participate in the Inv€$tival Showcase in Partnership with Jefferies and the Jefferies 2018 London Healthcare Conference
09/11/2018
Basking Ridge, NJ, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences to Participate in the Inv€$tival Showcase in Partnership with Jefferies and the Jefferies 2018 London Healthcare Conference BASKING RIDGE, N.J [...]
Kane Biotech Records Significant Online Sales Growth from Amazon
09/11/2018
349% Year-over-Year Growth in October YTD Sales WINNIPEG, Manitoba, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”), today announced that it has [...]
Cytori to Webcast Third Quarter Financial Results on November 14
09/11/2018
SAN DIEGO, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) will provide a live webcast of its third quarter financial results and business update on Wednesday, November 14, 2018 at 5:30 PM [...]

Pages